Depletion of thymus dependent lymphocytes in Hodgkin's disease.
D000818:Animals; D003520:Cyclophosphamide / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006689:Hodgkin Disease / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D006801:Humans; D007104:Immune Adherence Reaction; D007111:Immunity, Cellular; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012756:Sheep / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014747:Vinblastine / Q000627:therapeutic use
D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide; D011241:Prednisone